The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature

被引：2
作者：
Holoshitz N. [1 ]
Kavinsky C.J. [1 ]
Hijazi Z.M. [1 ]
机构：
[1] Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, IL, 60612
来源：
Cardiology and Therapy | 2012年 / 1卷 / 1期
关键词：
Aortic stenosis; Cardiology; Edwards SAPIEN valve; Interventional cardiology; Stents; Transcatheter aortic valve replacement;
D O I：
10.1007/s40119-012-0006-8
中图分类号：
学科分类号：
摘要：
The Edwards SAPIEN™ transcatheter heart valve (Edwards Lifesciences LLC, Irvine, CA, USA) is approved by the US Food and drug administration for use in the aortic position in patients with severe aortic stenosis who are not surgical candidates. This approval was backed by data from the Placement of AoRTic TraNscathetER Valve (PARTNER) I clinical trial, which showed the valve to be superior to standard medical therapy in high-risk nonoperative patients in cohort B of the trial. Although insertion of the valve is considered to be very safe, stroke, major vascular complications, and conduction abnormalities are the most frequent procedural complications. A dedicated team of physicians trained in structural cardiac interventions, including two interventional cardiologists, an echocardiographer, and a cardiac surgeon, are involved in every case. Improvements in valve design and streamlining of the delivery system, as well as favorable long-term outcomes, will hopefully pave the way for wider patient use in the future. © 2012 The Author(s).
引用
收藏
页码：1 / 17
页数：16
相关论文
共 43 条
  • [1] Davies H., Catheter mounted valve for temporary relief of aortic insufficiency, Lancet, 1, (1965)
  • [2] Anderson H.R., Knudsen L.L., Hasemkam J.M., Transluminal implantation of artificial heart valves: description of a new expandable aortic valve and initial result in implantation in closed chest pigs, Eur Heart J, 13, pp. 704-708, (1992)
  • [3] Bonhoeffer P., Boudjemline Y., Saliba Z., Et al., Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction, Lancet, 356, pp. 1403-1405, (2000)
  • [4] Cribier A., Eltchaninoff H., Bash A., Borenstein N., Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis, Circulation, 106, pp. 3006-3008, (2002)
  • [5] News and Events: News Room: Press Announcement, (2012)
  • [6] Lindroos M., Kupari M., Heikkila J., Tilvis R., Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample, J Am Coll Cardiol, 21, pp. 1220-1225, (1993)
  • [7] Ross Jr. J., Braunwald E., Aortic stenosis, Circulation, 38, pp. 61-67, (1968)
  • [8] Turina J., Hess O., Sepulcri F., Krayenbuehl H.P., Spontaneous course of aortic valve disease, Eur Heart J, 8, pp. 471-483, (1987)
  • [9] Schwarz F., Baumann P., Manthey J., Et al., The effect of aortic valve replacement on survival, Circulation, 66, pp. 1105-1110, (1982)
  • [10] Lund O., Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention, Circulation, 82, pp. 124-139, (1990)
12345